awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36665330-73595AD7-B12C-4972-9E1A-63FBC7473FF6
Q36665330-73595AD7-B12C-4972-9E1A-63FBC7473FF6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36665330-73595AD7-B12C-4972-9E1A-63FBC7473FF6
Minimal residual disease in chronic lymphocytic leukaemia: is it ready for primetime?
P2860
Q36665330-73595AD7-B12C-4972-9E1A-63FBC7473FF6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36665330-73595AD7-B12C-4972-9E1A-63FBC7473FF6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
69bd4f3bf03b9f54b7e57e36f83d773beccdc287
P2860
Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.